HOME >> MEDICINE >> NEWS
Brief motivational interviews work best long term for college students sent to alcohol counseling

Students who break university rules on alcohol and drug use in residence halls are often sent to counseling or educational programs. Little is known about the long-term effectiveness of these interventions. New findings show that the effects of brief motivational interviews on drinking problems are still apparent 15 months after initiation.

Results are published in the August issue of Alcoholism: Clinical & Experimental Research.

"Here at Rutgers University, all colleges require students who have violated university rules regarding alcohol and drug use in residence halls to attend three sessions at our Alcohol and Other Drug Assistance Program for Students (ADAPS)," said Helene Raskin White, professor of sociology with a joint appointment in the Center of Alcohol Studies and the Sociology Department.

While some universities may require an alcohol-education class, others may choose to impose a large fine such as $300 which often forces students to tell their parents, and some actually contact the parents.

"The Rutgers ADAPS program was already using an in-person brief motivational interview (BMI) intervention based on the Brief Alcohol Screening Intervention for College Students model," said White, who is also the study's corresponding author. "The ADAPS clinicians asked me to evaluate their program. Given that some studies ... had found that written feedback was efficacious, we decided to use the written personal feedback condition (WF) as the comparison group for this study."

White and her colleagues tracked 348 mandated students (209 males, 139 females), randomly assigned to either in-person personal feedback intervention within the context of a BMI (n=180) or WF only (n=168), examining them at four and 15 months after the interventions. Most of the students (88%) were referred for an alcohol violation.

"Students in both groups reduced their drinking and related problems between the b
'"/>


24-Jul-2007


Page: 1 2

Related medicine news :

1. Brief, high-dose steroid treatment offers extended relief to giant cell arteritis patients
2. The IOF World Congress on Osteoporosis (IOF WCO) Opening Media Briefing June 2
3. Nation sees downward trend in primary care: Press Briefing Teleconference
4. News Briefs from the January issue of CHEST
5. Obese girls less likely to attend college
6. Going to bed late may affect the health, academic performance of college students
7. Binge drinking leads to neurocognitive deficits among college students
8. Friends have greater sway on college students beliefs on drinking behavior
9. K-State professors study risk attitudes and consequences of college drinking
10. Over 80 percent of college girls surveyed diet to lose weight
11. Coping with crisis on campus: Conference will focus on college mental health issues after disasters

Post Your Comments:
(Date:5/23/2013)... FL (PRWEB) May 23, 2013 ... regenerative medicine company focused on the commercialization of ... and regeneration, today announced that the Company and ... million grant, for which AxoGen’s portion is approximately ... administrated by the U.S. Department of Defense (DoD) ...
(Date:5/23/2013)... 2013 Hile Design LLC is pleased ... awarded a Silver Creative Award at the Summit International ... entry was for its “Open Doors” animation promoting Scio ... in the 2013 District 6 ADDY Awards for the ... Creative Award recognizes and celebrates the creative achievements of ...
(Date:5/23/2013)... Utah (PRWEB) May 23, 2013 Registered ... R.D., published an article today on Tatalou.com offering helpful ... vacation. , The article, titled “ How to Stay ... important to carry hand sanitizer, when it’s safe to ... out for seafood, the importance of staying hydrated and ...
(Date:5/23/2013)... OH and Durham, NC (PRWEB) May 23, 2013 ... and commercialization firm that funds and develops innovative ... Deep Brain Innovations, LLC (DBI). DBI will ... optimize deep brain stimulation (DBS) therapy for patients ... is effective in treating Parkinson’s disease and generates ...
(Date:5/23/2013)... Consortium, Ltd., issued the following statement today on ... Reform of chemical safety legislation will succeed only ... Ensuring the safety and appropriate use of chemicals ... Toxic Substances Control Act is a critical opportunity ... transforming toxicity testing "from a system based on ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 2Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 3Health News:How to Stay Healthy While Traveling 2Health News:NDI Launches Deep Brain Innovations, LLC 2Health News:NDI Launches Deep Brain Innovations, LLC 3
(Date:5/22/2013)... PLAINS, N.Y. , May 22, 2013  The ... million to Valor Biotherapeutics, LLC, a joint ... of pre-clinical development, manufacturing, and a Phase I clinical ... the poor outcomes faced by many patients with indolent ... rituximab. Valor,s protein, IGN002, is a ...
(Date:5/22/2013)... CAESAREA, Israel , May 22, 2013 ... presented from the DEFLECT-I study demonstrates that Keystone Heart,s ... volume during TAVR (Transcatheter Aortic Valve Replacement) procedures when ... Advisory Board announces consensus on the importance of preserving ... and need for cerebral protection during cardiovascular procedures to ...
(Date:5/22/2013)... -- For the 3% of the population that suffer from ... anxiety-inducing and disabling.  While more than half of these ... hyperhidrosis is a serious medical condition.  Finally, there is ... Dr. Bruce Katz , ... New York , is leading an ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4Is There Finally A Way To Stop Severe Excessive Sweating? 2
Cached News: